Extrait

This phase II trial studies how well pazopanib hydrochloride works in treating patients with advanced or progressive malignant pheochromocytoma or paraganglioma. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Critère d'inclusion

• Extra-Adrenal Paraganglioma,Metastatic Adrenal Gland Pheochromocytoma,Paraganglioma,Recurrent Adrenal Gland Pheochromocytoma

Liens

• ictrp
• nct